Cancer

  • Breast and ovarian cancer newly linked to thousands of gene variants

    Breast and ovarian cancer newly linked to thousands of gene variants

    Scientists have pinpointed thousands of genetic changes in a gene that may increase a person’s risk of developing breast and ovarian cancer, paving the way for better risk assessment and more personalised care.  Researchers from the Wellcome Sanger Institute and their collaborators focused on the ‘cancer protection’ gene RAD51C, finding over 3,000 harmful genetic changes [...]

  • First patient receives cannabis medicine as breast cancer therapy

    First patient receives cannabis medicine as breast cancer therapy

    The first patient has received BRC-001, an experimental supportive care therapy for breast cancer patients. Researchers from City of Hope, a cancer research and treatment organisations in the United States, are evaluating whether this cannabinoid therapeutic candidate could address joint pain (arthralgia) that is often a side effect of aromatase inhibitors, a type of hormone [...]

  • False-positive mammogram results discourage women from future screenings

    False-positive mammogram results discourage women from future screenings

    A new study has has found that women who received a false-positive result that required additional imaging or biopsy were less likely to return for that follow-up screening. Early detection of breast cancer through mammography screening continues to save lives. However, abnormal findings on mammograms can lead to women being recalled for additional imaging and [...]

  • AI to check breast cancer scans in groundbreaking NHS trial

    AI to check breast cancer scans in groundbreaking NHS trial

    The technology could help doctors find malignancies in mammograms, freeing up clinical time

  • Global partnership to improve diagnostic accuracy of breast cancer

    Global partnership to improve diagnostic accuracy of breast cancer

    A new partnership aims to advance AI-enabled digital pathology for end-to-end breast tumour profiling PathPresenter, a digital pathology platform and 4D Path, a Boston company producing computer-aided cancer diagnostic products, are announcing a global partnership to distribute 4D Q-plasia OncoReader Breast within the new clinical workflow platform, ClinPx. The 4D Q-plasia OncoReader Breast uses digitised [...]